viagra livraison express medicament generic cialis superactive http://kanab.utah.gov/aberad.php?pharmac... viagra en libre vente en france http://unit-tice.emn.fr/IMG/old-nick.php... viagra a acheter viagra sur les femmes http://www.paysnedelamer.fr/?comps=2813&... http://www.paysnedelamer.fr/?comps=3195&... viagra halbe tablette trustedtablets levitra cialis online ohne rezept venlafaxine pharmacie leukeran prezzo acquistare dostinex on line
http://www.periodiques-caraibeamazonie.f... prix boite viagra cialis pharmacie europenne
  • http://humanidades.uprrp.edu/index.php?s... http://humanidades.uprrp.edu/index.php?s... http://humanidades.uprrp.edu/index.php?s...
  • Tag Archive | "radiation therapy"

    In one study, lower dose treatment for HPV oropharyngeal cancers is successful

    Wednesday, June 25, 2014

    0 Comments

    Author: Anthony Cmelak, M.D. Source: medicalnewstoday.com   A new study suggests that lowering the dose of radiation therapy for some head and neck cancer patients may improve outcomes and cause fewer long-term side effects. The research was presented by lead author Anthony Cmelak, M.D., professor of Radiation Oncology at Vanderbilt-Ingram Cancer Center (VICC), during the 50th annual meeting […]

    Continue reading...

    Lower radiation dose may be given to HPV-positive head and neck cancer patients

    Friday, June 20, 2014

    0 Comments

    Source: Vanderbilt University Published: June 19, 2014 By: Dagny Stuart   A new study suggests that lowering the dose of radiation therapy for some head and neck cancer patients may improve outcomes and cause fewer long-term side effects. The research was presented by lead author Anthony Cmelak, M.D., professor of Radiation Oncology at Vanderbilt-Ingram Cancer […]

    Continue reading...

    Study: Recurrence of SCCOP may differ in HPV-positive and HPV-negative patients

    Monday, February 24, 2014

    0 Comments

    Source: News Medical Published: February 21, 2014   Patients with HPV-positive squamous cell carcinoma of the oropharynx (SCCOP) had a longer time to development of distant metastasis (DM) after initial treatment, and had more metastatic sites in more atypical locations compared to HPV-negative patients, according to research presented today at the 2014 Multidisciplinary Head and […]

    Continue reading...

    Are combination therapies effective for advanced SCCHN?

    Tuesday, March 12, 2013

    0 Comments

    Source: Author: DrBicuspid Staff In a recent study, researchers from the University of North Carolina (UNC) Lineberger Comprehensive Cancer Center examined whether the addition of multiple drugs to radiation therapy is superior to the current standard of care therapy with one drug and radiation for locally advanced squamous cell carcinoma of the head and neck […]

    Continue reading...

    Reirradiation for Recurrent Head and Neck Cancer

    Wednesday, December 5, 2012

    0 Comments

    Source: Medscape News Date: November 29, 2012 Abstract Recurrence of head and neck cancer in a previously irradiated volume presents a challenging problem and has poor prognosis. A minority of patients are eligible for the preferred therapy, surgical resection. Systemic therapy is offered to patients with unresectable disease but offers little, if any, chance of […]

    Continue reading...

    CMC gets $8M to study oral damage from radiation

    Friday, September 28, 2012

    0 Comments

    Source: wcnc.com by Karen Garloch / The Charlotte Observer A research team in the Department of Oral Medicine at Carolinas Medical Center has received an $8 million grant from the National Institutes of Health to study tissue damage in patients who have received high-dose radiation for head and neck cancer. Hospital officials said it is […]

    Continue reading...

    Oropharyngeal cancer patients with HPV have a more robust response to radiation therapy

    Thursday, September 27, 2012

    0 Comments

    Source: Eurekalert.org (SACRAMENTO, Calif.) — UC Davis cancer researchers have discovered significant differences in radiation-therapy response among patients with oropharyngeal cancer depending on whether they carry the human papillomavirus (HPV), a common sexually transmitted virus. The findings, published online today in The Laryngoscope Journal, could lead to more individualized radiation treatment regimens, which for many […]

    Continue reading...

    Robots vs. radiation

    Friday, July 13, 2012

    0 Comments

    Source: the-scientist.com Author: Bob Grant Scientists at London, Ontario-based Lawson Health Research Institute have launched the first ever study of the comparative effectiveness of robotic-assisted surgery versus radiation therapy for the treatment of oropharyngeal cancer, or cancer of the back of the throat. Transoral robotic surgery (TORS), a new method for removing tumors from the […]

    Continue reading...

    Robotic Surgery Is Useful Option for Oral Cancer

    Monday, April 30, 2012

    0 Comments

    Source: Onclive.com Minimally invasive transoral robotic surgery (TORS), used alone or combined with adjuvant therapy, provides good functional and oncologic outcomes in patients with oropharyngeal squamous cell carcinoma (OPSCC), new research suggests. The results were especially impressive in patients with human papillomavirus (HPV) infection, which is currently the most common cause of OPSCC in Europe […]

    Continue reading...

    Prognostic Significance of HPV Status in Oropharyngeal Cancer

    Wednesday, April 18, 2012

    0 Comments

    OncologySTAT Editorial Team Dr. Maura Gillison is Professor of Medicine, Epidemiology, and Otolaryngology at Ohio State University in Columbus. OncologySTAT: The results of the Radiation Therapy Oncology Group (RTOG) 0129 trial showed that the human papillomavirus (HPV) is an independent prognostic factor in oropharyngeal cancer. Could you tell us about the rationale for this study? […]

    Continue reading...